The findings collected from the present study supported the promoting effect of MIAT shuttled by serum‐derived EVs on the atrial remodeling and the resultant AF by disrupting miR‐485‐5p‐mediated CXCL10 inhibition. This evidence concerns the gene CXCL10 and atrial fibrillation.